Who should join?

We welcome clinicians, researchers, and allied health professionals working in haematological malignancies with an interest in the care of older adults, including:

  • Haematologists and haematologic oncologists
  • Geriatricians
  • Medical, radiation, and surgical oncologists
  • Palliative care physicians
  • Clinical trialists and translational scientists
  • Epidemiologists and outcomes researchers
  • Oncology and haematology nurses
  • Advanced practice providers
  • Pharmacists
  • Rehabilitation specialists, physical therapists, and occupational therapists
  • Nutritionists and dietitians
  • Social workers and psychologists
  • Care coordinators and clinical research coordinators
  • Fellows, residents, and early-career investigators in ageing and haematological malignancies

The SIOG Haematology Interest Group was established to advance the care of older adults with haematological malignancies within SIOG and across the field.

Blood cancers disproportionately affect older adults, yet treatment decisions in haematology are often based on evidence from younger, fitter populations. Geriatric assessment remains inconsistently applied across haematology practice, and older adults are significantly underrepresented in haematology clinical trials.

The Haematology Interest Group brings together SIOG members from across disciplines to address these gaps — promoting ageing-informed research, integrating geriatric assessment into clinical decision-making, and strengthening the evidence base for older adults with blood cancers.

Focus

The group will build an international network of clinicians and researchers working at the intersection of geriatrics and haematological oncology.

Planned activities include hematology-focused sessions at the SIOG Annual Conference, collaborative research projects using existing datasets and registries, and engagement with related societies including EHA, ASH, and EuGMS. The group will also support trainee and early-career investigator participation in geriatric haematology research.

Get involved

For more information, contact the SIOG Head Office

Membership benefits

  • Connect with a global network of clinicians and researchers in geriatric haematology
  • Participate in SIOG activities and contribute to educational initiatives
  • Engage in collaborative research, including multinational dataset analyses
  • Contribute to hematology-focused sessions at the SIOG Annual Conference
  • Share clinical care models and implementation strategies across institutions
  • Engage with early-career investigators and support the next generation in the field

Key topics and priorities

  • Geriatric assessment in haematological malignancies — standardisation and integration into clinical care and trials
  • Treatment optimisation for older adults with blood cancers
  • Patient-reported outcomes and functional endpoints alongside survival outcomes
  • Frailty biology and heterogeneity of ageing in haematological cancers
  • Representation of older adults in haematology clinical trials
  • Implementation of ageing-informed care models globally
  • Survivorship and long-term functional outcomes in lymphoma, leukaemia, myeloma, and other blood disorders

Activities

  • Educational sessions at the SIOG Annual Conference
  • Collaborative multinational research projects
  • Engagement with EHA, ASH, and EuGMS
  • Dataset and registry analyses
  • Grant development and multicenter research initiatives
  • Opportunities for trainee and early-career investigator participation

Publications

Publications

Read the latest articles published by the Haematology Interest Group.

Community Portal

Community Portal

The SIOG Community Portal is accessible to SIOG members.

Forum

Forum

SIOG’s Haematology Interest Group organises regular calls to discuss ongoing and upcoming projects. These are open to SIOG members only.